Interstitial Lung Disease Trial, Not Yet Recruiting NCT06521125 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Not Yet Recruiting

NCT06521125
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • You are 18 years of age or older at the time of signing the consent form
  • You have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) — a specific type of lung scarring disease — confirmed by a chest scan and, if available, a lung tissue sample
  • You have a type of lung scarring condition that runs in your family, meaning at least one other biological family member also has a similar lung scarring condition
  • You have at least one close biological relative (such as a parent, child, or sibling) who is over 40 years old

For first-degree biological relatives (e.g., parents, children, or siblings of patients):

  • You are 40 years of age or older

Who may not be able to join:

For patients:

  • You have a lung scarring condition that is caused by something other than IPF, such as a condition related to an autoimmune disease, a medication, or inflammation causing granules in the lungs
  • You are unwilling or unable to sign the consent form

For first-degree biological relatives:

  • You have already been diagnosed with IPF
  • You have a history of severe anxiety, severe depression, thoughts of suicide, or another serious mental health condition that required a hospital stay (confirm with trial site)
  • You are unwilling or unable to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0630157857

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 September 2026

Primary endpoints

Prevalence of ILA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov